Ocular Therapeutix
OCUL
#5754
Rank
A$1.85 B
Marketcap
A$8.42
Share price
-4.95%
Change (1 day)
-55.60%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2026 (TTM): -A$0.45 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are A$52.05 Million. In 2025 the company made an earning of -A$0.41 Billion a decrease over its 2024 earnings that were of -A$0.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.45 Billion10.39%
2025 -A$0.41 Billion37.43%
2024 -A$0.3 Billion139.68%
2023 -A$0.13 Billion13.65%
2022 -A$0.11 Billion984.05%
2021 -A$9.91 Million-95.79%
2020 -A$0.24 Billion80.19%
2019 -A$0.14 Billion44.01%
2018 -A$90.62 Million-5.38%
2017 -A$95.77 Million41.79%
2016 -A$67.54 Million12.47%
2015 -A$60.06 Million38.75%
2014 -A$43.29 Million115.12%
2013 -A$20.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-A$16.94 Million-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
-A$7.74 Million-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-A$0.25 Billion-46.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.26 B-158.70%๐Ÿ‡บ๐Ÿ‡ธ USA